This is an uncopyedited electronic version of an article accepted for publication in Diabetes Care. The American Diabetes Association, publisher of Diabetes Care, is not responsible for any errors or omissions in this version of the manuscript or any version derived from it by third parties. The definitive publisher-authenticated version will be available in a future issue of Diabetes Care in print and online a
Atherosclerosis is the leading cause of mortality and morbidity in the developed world. It is charac...
OBJECTIVE: To determine whether information from genetic risk variants for diabetes is associated wi...
BACKGROUND: Contradictory results have been reported regarding the association between Pro12Ala poly...
OBJECTIVE — Activation of peroxisome proliferator–activated receptor (PPAR)- signaling influences m...
Several studies suggest that the peroxisome proliferator-activated receptor gamma (PPARγ) is involve...
Objective: Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) gene is one of the possible genes l...
Several studies suggest that the peroxisome proliferator-activated receptor gamma (PPAR gamma) is in...
Genetic association studies are viewed as problematic and plagued by irreproducibility. Many associa...
Background: Common variants of the PPARA gene have been found to associate with ischaemic heart dise...
Abstract Background Peroxisome proliferator-activated receptor γ (PPARγ) is a ligand-activated trans...
Objective: The Pro12Ala polymorphism of PPARG modulates risk of developing type 2 diabetes. The Ala ...
Single nucleotide polymorphisms (SNPs) in the peroxisome proliferator-activated receptor γ (PPARG) g...
Activation of peroxisome proliferator-activated receptor alpha (PPARα) occurs in animal models of di...
Peroxisome proliferator-activated receptor alpha (PPARα) is a member of the steroid hormone receptor...
ObjectivesPPARγ variants cause lipodystrophy, insulin resistance, and diabetes. This study aimed to ...
Atherosclerosis is the leading cause of mortality and morbidity in the developed world. It is charac...
OBJECTIVE: To determine whether information from genetic risk variants for diabetes is associated wi...
BACKGROUND: Contradictory results have been reported regarding the association between Pro12Ala poly...
OBJECTIVE — Activation of peroxisome proliferator–activated receptor (PPAR)- signaling influences m...
Several studies suggest that the peroxisome proliferator-activated receptor gamma (PPARγ) is involve...
Objective: Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) gene is one of the possible genes l...
Several studies suggest that the peroxisome proliferator-activated receptor gamma (PPAR gamma) is in...
Genetic association studies are viewed as problematic and plagued by irreproducibility. Many associa...
Background: Common variants of the PPARA gene have been found to associate with ischaemic heart dise...
Abstract Background Peroxisome proliferator-activated receptor γ (PPARγ) is a ligand-activated trans...
Objective: The Pro12Ala polymorphism of PPARG modulates risk of developing type 2 diabetes. The Ala ...
Single nucleotide polymorphisms (SNPs) in the peroxisome proliferator-activated receptor γ (PPARG) g...
Activation of peroxisome proliferator-activated receptor alpha (PPARα) occurs in animal models of di...
Peroxisome proliferator-activated receptor alpha (PPARα) is a member of the steroid hormone receptor...
ObjectivesPPARγ variants cause lipodystrophy, insulin resistance, and diabetes. This study aimed to ...
Atherosclerosis is the leading cause of mortality and morbidity in the developed world. It is charac...
OBJECTIVE: To determine whether information from genetic risk variants for diabetes is associated wi...
BACKGROUND: Contradictory results have been reported regarding the association between Pro12Ala poly...